skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Botulinum toxin type A for the management of glabellar rhytids

Review

(2765) Views  (1579) Full article downloads

Authors: Anne Marie Tremaine, Jerry L McCullough

Published Date April 2010 Volume 2010:3 Pages 15 - 23
DOI: http://dx.doi.org/10.2147/CCID.S6492

Anne Marie Tremaine, Jerry L McCullough

Department of Dermatology, University of California, Irvine, CA, USA

Abstract: There is an increasing demand for minimally-invasive cosmetic procedures to arrest the aging process. Botulinum toxin type A injections are the most commonly used nonsurgical cosmetic procedures in the United States. There has been research spanning over two decades dedicated to safety, efficacy, dosing, and complications of botulinum toxin type A. There are now two Food and Drug Administration (FDA) approved botulinum toxin type A options in the United States: Botox® and Dysport™, with new advances being made in the field.

Keywords: botulinum toxin type A, glabella, Botox, Dysport, complications, dosing








Readers of this article also read:
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • American Acne and Rosacea Society

    The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.